| pubmed-article:16952921 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16952921 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16952921 | lifeskim:mentions | umls-concept:C0018799 | lld:lifeskim |
| pubmed-article:16952921 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
| pubmed-article:16952921 | lifeskim:mentions | umls-concept:C2709270 | lld:lifeskim |
| pubmed-article:16952921 | lifeskim:mentions | umls-concept:C0348026 | lld:lifeskim |
| pubmed-article:16952921 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
| pubmed-article:16952921 | lifeskim:mentions | umls-concept:C0678594 | lld:lifeskim |
| pubmed-article:16952921 | lifeskim:mentions | umls-concept:C0205164 | lld:lifeskim |
| pubmed-article:16952921 | pubmed:issue | 19 | lld:pubmed |
| pubmed-article:16952921 | pubmed:dateCreated | 2006-9-19 | lld:pubmed |
| pubmed-article:16952921 | pubmed:abstractText | To assess the role of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in the diagnosis of major structural heart disease (MSHD) in patients with atrial fibrillation (AF) compared with those with sinus rhythm (SR) using receiver operator characteristic (ROC) analysis. NT-proBNP is elevated in MSHD and heart failure (HF). AF, a common finding in HF and MSHD, is also associated with raised plasma NT-proBNP. As a result, the utility of NT-proBNP for predicting MSHD may be reduced. | lld:pubmed |
| pubmed-article:16952921 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16952921 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16952921 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16952921 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16952921 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16952921 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16952921 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16952921 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:16952921 | pubmed:issn | 0195-668X | lld:pubmed |
| pubmed-article:16952921 | pubmed:author | pubmed-author:ClarkAndrew... | lld:pubmed |
| pubmed-article:16952921 | pubmed:author | pubmed-author:ClelandJohn... | lld:pubmed |
| pubmed-article:16952921 | pubmed:author | pubmed-author:RigbyAlan SAS | lld:pubmed |
| pubmed-article:16952921 | pubmed:author | pubmed-author:GoodeKevinK | lld:pubmed |
| pubmed-article:16952921 | pubmed:author | pubmed-author:SheltonRhidia... | lld:pubmed |
| pubmed-article:16952921 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16952921 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:16952921 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16952921 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16952921 | pubmed:pagination | 2353-61 | lld:pubmed |
| pubmed-article:16952921 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:16952921 | pubmed:meshHeading | pubmed-meshheading:16952921... | lld:pubmed |
| pubmed-article:16952921 | pubmed:meshHeading | pubmed-meshheading:16952921... | lld:pubmed |
| pubmed-article:16952921 | pubmed:meshHeading | pubmed-meshheading:16952921... | lld:pubmed |
| pubmed-article:16952921 | pubmed:meshHeading | pubmed-meshheading:16952921... | lld:pubmed |
| pubmed-article:16952921 | pubmed:meshHeading | pubmed-meshheading:16952921... | lld:pubmed |
| pubmed-article:16952921 | pubmed:meshHeading | pubmed-meshheading:16952921... | lld:pubmed |
| pubmed-article:16952921 | pubmed:meshHeading | pubmed-meshheading:16952921... | lld:pubmed |
| pubmed-article:16952921 | pubmed:meshHeading | pubmed-meshheading:16952921... | lld:pubmed |
| pubmed-article:16952921 | pubmed:meshHeading | pubmed-meshheading:16952921... | lld:pubmed |
| pubmed-article:16952921 | pubmed:meshHeading | pubmed-meshheading:16952921... | lld:pubmed |
| pubmed-article:16952921 | pubmed:meshHeading | pubmed-meshheading:16952921... | lld:pubmed |
| pubmed-article:16952921 | pubmed:meshHeading | pubmed-meshheading:16952921... | lld:pubmed |
| pubmed-article:16952921 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16952921 | pubmed:articleTitle | The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. | lld:pubmed |
| pubmed-article:16952921 | pubmed:affiliation | Department of Cardiology, Castle Hill Hospital, Cottingham, Kingston-upon-Hull HU16 5JQ, UK. rhidianshelton@btopenworld.com | lld:pubmed |
| pubmed-article:16952921 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16952921 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16952921 | lld:pubmed |
